Nisa Investment Advisors, LLC Geron Corp Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Geron Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 6,265 shares of GERN stock, worth $22,178. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,265

Previous 6,116 2.44%

Holding current value

$22,178

Previous $25,000 12.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$4.17 - $4.99 $621 - $743	149 Added 2.44%	6,265 $28,000
Q2 2024 Jul 19, 2024	BUY	$3.1 - $5.09 $1,199 - $1,969	387 Added 6.76%	6,116 $25,000
Q1 2024 May 01, 2024	BUY	$1.75 - $3.44 $873 - $1,716	499 Added 9.54%	5,729 $18,000
Q4 2023 Jan 25, 2024	SELL	$1.74 - $2.31 $17 - $23	-10 Reduced 0.19%	5,230 $11,000
Q3 2023 Nov 02, 2023	SELL	$2.11 - $3.28 $19,475 - $30,274	-9,230 Reduced 63.79%	5,240 $11,000
Q2 2023 Aug 11, 2023	BUY	$1.97 - $3.69 $6,008 - $11,254	3,050 Added 26.71%	14,470 $46,000
Q1 2023 May 02, 2023	BUY	$2.14 - $3.4 $13,225 - $21,012	6,180 Added 117.94%	11,420 $25,000
Q4 2022 Feb 02, 2023	BUY	$2.03 - $2.42 $180 - $215	89 Added 1.73%	5,240 $13,000
Q3 2022 Nov 07, 2022	BUY	$1.67 - $2.94 $519 - $914	311 Added 6.43%	5,151 $11,000
Q4 2021 Feb 03, 2022	SELL	$1.22 - $1.72 $206,199 - $290,707	-169,016 Reduced 97.22%	4,840 $5,000
Q3 2021 Oct 18, 2021	BUY	$1.2 - $1.5 $146,959 - $183,699	122,466 Added 238.31%	173,856 $238,000
Q2 2021 Aug 06, 2021	BUY	$1.25 - $1.83 $58,187 - $85,186	46,550 Added 961.78%	51,390 $72,000
Q4 2020 Jan 25, 2021	BUY	$1.55 - $2.05 $2,557 - $3,382	1,650 Added 51.72%	4,840 $8,000
Q3 2019 Oct 17, 2019	BUY	$1.15 - $1.59 $2,438 - $3,370	2,120 Added 198.13%	3,190 $4,000
Q3 2018 Oct 16, 2018	BUY	$1.76 - $6.38 $1,883 - $6,826	1,070 New	1,070 $2,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.34B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Geron Corp Transaction History